Table 3.
Effects of in ovo application of epidermal growth factor (EGF) on expression of EGF receptor from day 17 (E17) of incubation through to hatching (E21).
Incubation, day | EGF1, μg | Relative expression |
---|---|---|
E17 | 0 | 1.02b |
E17 | 160 | 1.91b |
E17 | 640 | 1.43b |
E18 | 0 | 1.01b |
E18 | 160 | 0.90b |
E18 | 640 | 0.54b |
E19 | 0 | 1.06b |
E19 | 160 | 1.38b |
E19 | 640 | 1.62b |
E20 | 0 | 1.00b |
E20 | 160 | 1.87b |
E20 | 640 | 0.91b |
E21 | 0 | 1.07b |
E21 | 160 | 4.43a |
E21 | 640 | 5.64a |
SEM | 0.517 | |
Main effect of incubation day | ||
E17 | 1.46b | |
E18 | 0.82b | |
E19 | 1.35b | |
E20 | 1.26b | |
E21 | 3.71a | |
SEM | 0.299 | |
Main effect of EGF1, μg | ||
0 | 1.03b | |
160 | 2.10a | |
640 | 2.03a | |
SEM | 0.23 | |
P value | ||
Sampling day | <0.01 | |
EGF | 0.01 | |
Sampling∗EGF | 0.002 |
Means assigned different letters (a, b) within a response criterion are significantly different, P < 0.05; n = 5.
Epidermal growth factor, μg/kg egg, was injected into amniotic sac of eggs on day 19 of incubation.